Curis Lifesciences Stock Screener | Share Price & Fundamental Analysis
CURIS
Pharmaceuticals
Screen Curis Lifesciences share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap
₹99.00 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
2.64
EPS (TTM)
₹10.29
Dividend Yield
-
Debt to Equity
1.48
52W High
-
52W Low
-
Operating Margin
30.00%
Profit Margin
11.11%
Revenue (TTM)
₹9.00
EBITDA
₹3.00
Net Income
₹1.00
Total Assets
₹43.00
Total Equity
₹16.00
Curis Lifesciences Share Price History - Stock Screener Chart
Screen CURIS historical share price movements with interactive charts. Analyze price trends and patterns.
Curis Lifesciences Company Profile - Fundamental Screener
Screen Curis Lifesciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CURIS shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE1BZN01016
Curis Lifesciences Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen CURIS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 43 | 34 | 30 | 27 |
| Current Assets | 31 | 22 | 17 | 15 |
| Fixed Assets | 11 | 12 | 12 | 12 |
| Liabilities | ||||
| Total Liabilities | 43 | 34 | 30 | 27 |
| Current Liabilities | 9 | 10 | 10 | 13 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 16 | 6 | 0 | -1 |
| Share Capital | 6 | 1 | 1 | 1 |
| Reserves & Surplus | 10 | 5 | 0 | -1 |
Screen CURIS income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2024-Jun |
|---|---|
| Revenue | 9 |
| Expenses | 6 |
| EBITDA | 3 |
| Operating Profit % | 30.00% |
| Depreciation | 0 |
| Interest | 0 |
| Profit Before Tax | 2 |
| Tax | 1 |
| Net Profit | 1 |
| EPS | 24.00 |
Curis Lifesciences Cash Flow Screener - Liquidity Fundamentals
Screen CURIS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | -2 | 0 | 3 | 5 |
| Investing Activities | 0 | 0 | -1 | 0 |
| Financing Activities | 2 | 0 | -3 | -5 |
| Net Cash Flow | 0 | 0 | 0 | 0 |
Screen CURIS shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Nov | 2025-Oct | 2025-Jun | 2024-Dec |
|---|---|---|---|---|
| Promoter Holding | 68.03% | 92.68% | 92.68% | 92.68% |
| FII Holding | 2.93% | 0.00% | 0.00% | 0.00% |
| DII Holding | 10.86% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 13.97% | 0.00% | 0.00% | 4.37% |
| Other Holding | 4.20% | 7.32% | 7.32% | 2.95% |
| Shareholder Count | 36 | 36 | 35 | 27 |
Curis Lifesciences Dividend Screener - Share Yield Analysis
Screen CURIS dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Curis Lifesciences Index Membership - Market Screener Classification
Screen CURIS by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Curis Lifesciences Market Events Screener - Corporate Actions
Screen CURIS market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-12-04 | 2025-12-04 | Quarterly Result Announcement | NA | -9.29% |
Curis Lifesciences Competitors Screener - Peer Comparison
Screen CURIS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,734 | 39.35 | 54,729 | 9.71% | 10,980 | 39.06 |
| Divis Laboratories | 168,851 | 68.64 | 9,712 | 18.67% | 2,191 | 44.96 |
| Torrent Pharmaceuticals | 129,357 | 60.42 | 11,539 | 6.99% | 1,911 | 59.35 |
| Cipla | 120,560 | 22.17 | 28,410 | 7.12% | 5,291 | 42.76 |
| Dr Reddys Laboratories | 105,648 | 18.42 | 33,741 | 16.73% | 5,725 | 49.97 |
| Lupin | 95,032 | 21.87 | 22,910 | 13.74% | 3,306 | 50.10 |
| Zydus Life Science | 90,707 | 18.03 | 23,511 | 18.55% | 4,615 | 34.06 |
| Mankind Pharma | 88,856 | 50.11 | 12,744 | 20.90% | 2,007 | 40.67 |
| Aurobindo Pharma | 68,901 | 20.16 | 32,346 | 9.43% | 3,484 | 46.33 |
| Alkem Laboratories | 65,390 | 26.89 | 13,458 | 3.70% | 2,216 | 37.45 |
Curis Lifesciences Company Announcements - News Screener
Screen CURIS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.